TRVI·89532M101·US·equity·Healthcare - Biotechnology-Activist
TRVI (TREVI THERAPEUTICS INC) is held by 102 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($122.2M), FMR LLC ($95.9M), WELLINGTON MANAGEMENT GROUP LLP ($61.9M). Net institutional sentiment: Mixed.
See how TRVI's score breaks down across 4 SEC sources
Showing 1-20 of 109
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer